ALC

Alcon AG

ALC.US alcon.com + Research + Basket
CIK 0001167379
ISIN CH0432492467
Employees 25,000
Phone 41 589 112 110
Fiscal year end December
IPO Apr 09, 2019
Address Chemin de Blandonnet 8, Geneva, Switzerland, 1214
71.45
+0.32 (+0.45%)
USD · NYSE
52-week range
61.84
87.22
Trading at 38% of the 52-week range
Market Cap
34.38B
P/E Ratio
53.89
Forward P/E
17.64
Book Value
44.67
Div. Yield
0.51%
% Institutions
62.56%
% Insiders
0.196%

1 Year

-3.3%

3 Year

+1.4%

10 Year

+25.7%
Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Actions

Add an action for ALC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. David J. Endicott CEO & Director 1965
Mr. Timothy C. Stonesifer Senior VP & CFO 1967
Mr. Ian Bell Senior VP & COO 1971
Margaret Buckley Chief Accounting Officer NA
Dr. Franck Leveiller Ph.D. SVP of Global Research & Development and Chief Scientific Officer NA
Mr. Muru Murugappan Senior VP and Chief Information & Transformation Officer NA
Mr. Royce R. Bedward J.D. Senior VP, General Counsel & Corporate Secretary 1966
Ms. Kimberly Martin Senior VP and Chief HR & Corporate Communications 1975
Mr. Leon Sergio Duplan Fraustro Senior VP & President of Americas 1968
Mr. Laurent Attias Senior VP of Corporate Strategy, Business Development and Licensing (BD&L), M&A 1968

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Capital Management, LLC 14.75M Jun 30, 2026 3.05% $0.02 -0.82%
Bank of New York Mellon Corp 13.06M Jun 30, 2026 2.70% $0.14 -16.67%
NORGES BANK 10.98M Jun 30, 2026 2.27% $0.07 -8.93%
Amvescap Plc. 10.38M Jun 30, 2026 2.15% $0.06 2,786.30%
Ako Capital Llp 9.68M Jun 30, 2026 2.00% $15.19 3.84%
Aristotle Capital Management LLC 9.15M Jun 30, 2026 1.89% $1.29 -5.82%
Zurcher Kantonalbank 7.92M Jun 30, 2026 1.64% $1.03 -1.34%
FMR Inc 7.66M Jun 30, 2026 1.59% $0.02 -38.34%
UBS Group AG 7.16M Jun 30, 2026 1.48% $0.06 20.65%
Amundi 6.64M Jun 30, 2026 1.37% $0.11 16.28%
Select Equity Group LP 5.77M Jun 30, 2026 1.19% $1.93 1.59%
Vontobel Holding Ltd. 5.64M Jun 30, 2026 1.17% $1.21 3.30%
Pictet Asset Manangement SA 5.53M Jun 30, 2026 1.14% $0.36 11.15%
Deutsche Bank AG 5.35M Jun 30, 2026 1.11% $0.10 7.36%
The Goldman Sachs Group Inc 4.68M Jun 30, 2026 0.97% $0.03 -19.70%
Vanguard Fiduciary Trust Co 4.32M Jun 30, 2026 0.89% $0.06 -0.90%
Allspring Global Investments Holdings, LLC 4.10M Jun 30, 2026 0.85% $0.42 -0.68%
Royal Bank of Canada 4.02M Jun 30, 2026 0.83% $0.04 -3.43%
Legal & General Group PLC 3.81M Jun 30, 2026 0.79% $0.05 -3.50%
Troy Asset Management Limited 3.80M Jun 30, 2026 0.79% $5.79 27.21%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Intl Stock Index Inv 7.20M 1.49% ▲ 0.29% Sep 30, 2026
2 Vanguard Developed Markets Index Admiral 4.75M 0.98% ▼ 0.33% Sep 30, 2026
3 iShares Core MSCI EAFE ETF 3.74M 0.77% ▲ 0.29% Sep 30, 2026
4 Allspring Special Mid Cap Value Inst 3.28M 0.68% ▲ 0.00% Sep 30, 2026
5 UBS(CH)IF Equities CH All NSL I-B-acc 3.09M 0.64% ▼ 0.00% Sep 30, 2026
6 Vanguard Windsor II Inv 2.92M 0.60% ▲ 0.00% Jun 30, 2026
7 Equities CH ESG All Index A-acc 2.66M 0.55% ▲ 215.36% Sep 30, 2026
8 SWC (CH) IEF Switzerland Ttl Resp GT CHF 2.49M 0.52% ▼ 0.61% Aug 31, 2026
9 MFS International Intrinsic Equity A 2.42M 0.50% ▲ 0.00% Sep 30, 2026
10 Vanguard International Growth Inv 2.29M 0.47% ▲ 11.57% Jun 30, 2026

Financial Highlights

▼
Market Cap: $34.38B
EBITDA: $2.40B
P/E Ratio: $53.89
PEG Ratio: $1.26
Book Value: $44.67
Dividend/Share: $0.35
Dividend Yield: 0.51%
Earnings/Share: $1.32
Profit Margin: 5.92%
Operating Margin: 14.63%
ROA (TTM): 2.80%
ROE (TTM): 2.94%
Revenue (TTM): $10.86B
Revenue/Share (TTM): $22.21
Earnings Growth (YOY): -44.60%
Revenue Growth (YOY): 8.70%

Valuation Metrics

Enterprise Value: $38.14B
Trailing P/E: 53.89
Forward P/E: 17.64

Shares Statistics

Shares Outstanding: 483.40M
Shares Float: 481.83M
% Insiders: 0.196%
% Institutions: 62.56%
Shares Short: 19.55M
Shares Short (Prior Month): 17.49M
Short Ratio: 10.62
Short % Float: 1.52%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$10.40B
Cost of Goods Sold
adjust
$-4.66B
Gross Profit
subtotal
$5.75B
SG&A
adjust
$-3.45B
R&D
adjust
$-990.00M
Operating Income
subtotal
$1.36B
Other / Non-Operating Items
adjust
$-380.00M
Net Income
subtotal
$980.00M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ALC.US!